0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Heparin Sodium Injection Market Research Report 2023
Published Date: April 2023
|
Report Code: QYRE-Auto-37F3406
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Heparin Sodium Injection Market Insights Forecast to 2028
BUY CHAPTERS

Global Heparin Sodium Injection Market Research Report 2023

Code: QYRE-Auto-37F3406
Report
April 2023
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Heparin Sodium Injection Market

Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
The global Heparin Sodium Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Heparin Sodium Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Heparin Sodium Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Heparin Sodium Injection include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Pfizer, Dongcheng Biochemicals, Changzhou Qianhong Bio-pharma, Changshan Biochemical, Pharma Action and Baxter, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Heparin Sodium Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Sodium Injection.
The Heparin Sodium Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Heparin Sodium Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin Sodium Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Global Heparin Sodium Injection Market Report

Report MetricDetails
Report NameGlobal Heparin Sodium Injection Market
Base Year2022
Forecasted years2023-2029
By Company
  • Shenzhen Hepalink
  • Bioibérica
  • Nanjing King-friend
  • Pfizer
  • Dongcheng Biochemicals
  • Changzhou Qianhong Bio-pharma
  • Changshan Biochemical
  • Pharma Action
  • Baxter
  • Dongying Tiandong Pharmaceutical
  • Opocrin
  • Aspen Oss
  • Xinbai Pharmaceuticals
  • Yino Pharma Limited
  • Sichuan Deebio
Segment by Type
  • 1, 000 USP Units / mL
  • 5, 000 USP Units / mL
  • 10, 000 USP Units / mL
Segment by Application
  • Treatment of Venous Thromboembolism
  • Complications of Pregnancy
  • Cardioversion of Atrial Fibrillation/Flutter
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
Forecast unitsUSD million in value
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Heparin Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Heparin Sodium Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.
1 Heparin Sodium Injection Market Overview
1.1 Product Overview and Scope of Heparin Sodium Injection
1.2 Heparin Sodium Injection Segment by Type
1.2.1 Global Heparin Sodium Injection Market Value Comparison by Type (2023-2029)
1.2.2 1, 000 USP Units / mL
1.2.3 5, 000 USP Units / mL
1.2.4 10, 000 USP Units / mL
1.3 Heparin Sodium Injection Segment by Application
1.3.1 Global Heparin Sodium Injection Market Value by Application: (2023-2029)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Other
1.4 Global Heparin Sodium Injection Market Size Estimates and Forecasts
1.4.1 Global Heparin Sodium Injection Revenue 2018-2029
1.4.2 Global Heparin Sodium Injection Sales 2018-2029
1.4.3 Global Heparin Sodium Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Heparin Sodium Injection Market Competition by Manufacturers
2.1 Global Heparin Sodium Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Heparin Sodium Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Heparin Sodium Injection Average Price by Manufacturers (2018-2023)
2.4 Global Heparin Sodium Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Heparin Sodium Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heparin Sodium Injection, Product Type & Application
2.7 Heparin Sodium Injection Market Competitive Situation and Trends
2.7.1 Heparin Sodium Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Heparin Sodium Injection Players Market Share by Revenue
2.7.3 Global Heparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Heparin Sodium Injection Retrospective Market Scenario by Region
3.1 Global Heparin Sodium Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Heparin Sodium Injection Global Heparin Sodium Injection Sales by Region: 2018-2029
3.2.1 Global Heparin Sodium Injection Sales by Region: 2018-2023
3.2.2 Global Heparin Sodium Injection Sales by Region: 2024-2029
3.3 Global Heparin Sodium Injection Global Heparin Sodium Injection Revenue by Region: 2018-2029
3.3.1 Global Heparin Sodium Injection Revenue by Region: 2018-2023
3.3.2 Global Heparin Sodium Injection Revenue by Region: 2024-2029
3.4 North America Heparin Sodium Injection Market Facts & Figures by Country
3.4.1 North America Heparin Sodium Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Heparin Sodium Injection Sales by Country (2018-2029)
3.4.3 North America Heparin Sodium Injection Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heparin Sodium Injection Market Facts & Figures by Country
3.5.1 Europe Heparin Sodium Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Heparin Sodium Injection Sales by Country (2018-2029)
3.5.3 Europe Heparin Sodium Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heparin Sodium Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Heparin Sodium Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Heparin Sodium Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Heparin Sodium Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heparin Sodium Injection Market Facts & Figures by Country
3.7.1 Latin America Heparin Sodium Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Heparin Sodium Injection Sales by Country (2018-2029)
3.7.3 Latin America Heparin Sodium Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heparin Sodium Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Heparin Sodium Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Heparin Sodium Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Heparin Sodium Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Heparin Sodium Injection Sales by Type (2018-2029)
4.1.1 Global Heparin Sodium Injection Sales by Type (2018-2023)
4.1.2 Global Heparin Sodium Injection Sales by Type (2024-2029)
4.1.3 Global Heparin Sodium Injection Sales Market Share by Type (2018-2029)
4.2 Global Heparin Sodium Injection Revenue by Type (2018-2029)
4.2.1 Global Heparin Sodium Injection Revenue by Type (2018-2023)
4.2.2 Global Heparin Sodium Injection Revenue by Type (2024-2029)
4.2.3 Global Heparin Sodium Injection Revenue Market Share by Type (2018-2029)
4.3 Global Heparin Sodium Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Heparin Sodium Injection Sales by Application (2018-2029)
5.1.1 Global Heparin Sodium Injection Sales by Application (2018-2023)
5.1.2 Global Heparin Sodium Injection Sales by Application (2024-2029)
5.1.3 Global Heparin Sodium Injection Sales Market Share by Application (2018-2029)
5.2 Global Heparin Sodium Injection Revenue by Application (2018-2029)
5.2.1 Global Heparin Sodium Injection Revenue by Application (2018-2023)
5.2.2 Global Heparin Sodium Injection Revenue by Application (2024-2029)
5.2.3 Global Heparin Sodium Injection Revenue Market Share by Application (2018-2029)
5.3 Global Heparin Sodium Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Shenzhen Hepalink
6.1.1 Shenzhen Hepalink Corporation Information
6.1.2 Shenzhen Hepalink Description and Business Overview
6.1.3 Shenzhen Hepalink Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Shenzhen Hepalink Heparin Sodium Injection Product Portfolio
6.1.5 Shenzhen Hepalink Recent Developments/Updates
6.2 Bioibérica
6.2.1 Bioibérica Corporation Information
6.2.2 Bioibérica Description and Business Overview
6.2.3 Bioibérica Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bioibérica Heparin Sodium Injection Product Portfolio
6.2.5 Bioibérica Recent Developments/Updates
6.3 Nanjing King-friend
6.3.1 Nanjing King-friend Corporation Information
6.3.2 Nanjing King-friend Description and Business Overview
6.3.3 Nanjing King-friend Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Nanjing King-friend Heparin Sodium Injection Product Portfolio
6.3.5 Nanjing King-friend Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Heparin Sodium Injection Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Dongcheng Biochemicals
6.5.1 Dongcheng Biochemicals Corporation Information
6.5.2 Dongcheng Biochemicals Description and Business Overview
6.5.3 Dongcheng Biochemicals Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Dongcheng Biochemicals Heparin Sodium Injection Product Portfolio
6.5.5 Dongcheng Biochemicals Recent Developments/Updates
6.6 Changzhou Qianhong Bio-pharma
6.6.1 Changzhou Qianhong Bio-pharma Corporation Information
6.6.2 Changzhou Qianhong Bio-pharma Description and Business Overview
6.6.3 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Product Portfolio
6.6.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
6.7 Changshan Biochemical
6.6.1 Changshan Biochemical Corporation Information
6.6.2 Changshan Biochemical Description and Business Overview
6.6.3 Changshan Biochemical Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Changshan Biochemical Heparin Sodium Injection Product Portfolio
6.7.5 Changshan Biochemical Recent Developments/Updates
6.8 Pharma Action
6.8.1 Pharma Action Corporation Information
6.8.2 Pharma Action Description and Business Overview
6.8.3 Pharma Action Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pharma Action Heparin Sodium Injection Product Portfolio
6.8.5 Pharma Action Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Baxter Heparin Sodium Injection Product Portfolio
6.9.5 Baxter Recent Developments/Updates
6.10 Dongying Tiandong Pharmaceutical
6.10.1 Dongying Tiandong Pharmaceutical Corporation Information
6.10.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.10.3 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product Portfolio
6.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.11 Opocrin
6.11.1 Opocrin Corporation Information
6.11.2 Opocrin Heparin Sodium Injection Description and Business Overview
6.11.3 Opocrin Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Opocrin Heparin Sodium Injection Product Portfolio
6.11.5 Opocrin Recent Developments/Updates
6.12 Aspen Oss
6.12.1 Aspen Oss Corporation Information
6.12.2 Aspen Oss Heparin Sodium Injection Description and Business Overview
6.12.3 Aspen Oss Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Aspen Oss Heparin Sodium Injection Product Portfolio
6.12.5 Aspen Oss Recent Developments/Updates
6.13 Xinbai Pharmaceuticals
6.13.1 Xinbai Pharmaceuticals Corporation Information
6.13.2 Xinbai Pharmaceuticals Heparin Sodium Injection Description and Business Overview
6.13.3 Xinbai Pharmaceuticals Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Xinbai Pharmaceuticals Heparin Sodium Injection Product Portfolio
6.13.5 Xinbai Pharmaceuticals Recent Developments/Updates
6.14 Yino Pharma Limited
6.14.1 Yino Pharma Limited Corporation Information
6.14.2 Yino Pharma Limited Heparin Sodium Injection Description and Business Overview
6.14.3 Yino Pharma Limited Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Yino Pharma Limited Heparin Sodium Injection Product Portfolio
6.14.5 Yino Pharma Limited Recent Developments/Updates
6.15 Sichuan Deebio
6.15.1 Sichuan Deebio Corporation Information
6.15.2 Sichuan Deebio Heparin Sodium Injection Description and Business Overview
6.15.3 Sichuan Deebio Heparin Sodium Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Sichuan Deebio Heparin Sodium Injection Product Portfolio
6.15.5 Sichuan Deebio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heparin Sodium Injection Industry Chain Analysis
7.2 Heparin Sodium Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heparin Sodium Injection Production Mode & Process
7.4 Heparin Sodium Injection Sales and Marketing
7.4.1 Heparin Sodium Injection Sales Channels
7.4.2 Heparin Sodium Injection Distributors
7.5 Heparin Sodium Injection Customers
8 Heparin Sodium Injection Market Dynamics
8.1 Heparin Sodium Injection Industry Trends
8.2 Heparin Sodium Injection Market Drivers
8.3 Heparin Sodium Injection Market Challenges
8.4 Heparin Sodium Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Heparin Sodium Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Heparin Sodium Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Heparin Sodium Injection Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Heparin Sodium Injection Sales (K Units) of Key Manufacturers (2018-2023)
    Table 5. Global Heparin Sodium Injection Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Heparin Sodium Injection Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Heparin Sodium Injection Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Heparin Sodium Injection Average Price (USD/Unit) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Heparin Sodium Injection, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Heparin Sodium Injection, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Heparin Sodium Injection, Product Type & Application
    Table 12. Global Key Manufacturers of Heparin Sodium Injection, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Heparin Sodium Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin Sodium Injection as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Heparin Sodium Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Heparin Sodium Injection Sales by Region (2018-2023) & (K Units)
    Table 18. Global Heparin Sodium Injection Sales Market Share by Region (2018-2023)
    Table 19. Global Heparin Sodium Injection Sales by Region (2024-2029) & (K Units)
    Table 20. Global Heparin Sodium Injection Sales Market Share by Region (2024-2029)
    Table 21. Global Heparin Sodium Injection Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Heparin Sodium Injection Revenue Market Share by Region (2018-2023)
    Table 23. Global Heparin Sodium Injection Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Heparin Sodium Injection Revenue Market Share by Region (2024-2029)
    Table 25. North America Heparin Sodium Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Heparin Sodium Injection Sales by Country (2018-2023) & (K Units)
    Table 27. North America Heparin Sodium Injection Sales by Country (2024-2029) & (K Units)
    Table 28. North America Heparin Sodium Injection Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Heparin Sodium Injection Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Heparin Sodium Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Heparin Sodium Injection Sales by Country (2018-2023) & (K Units)
    Table 32. Europe Heparin Sodium Injection Sales by Country (2024-2029) & (K Units)
    Table 33. Europe Heparin Sodium Injection Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Heparin Sodium Injection Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Heparin Sodium Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Heparin Sodium Injection Sales by Region (2018-2023) & (K Units)
    Table 37. Asia Pacific Heparin Sodium Injection Sales by Region (2024-2029) & (K Units)
    Table 38. Asia Pacific Heparin Sodium Injection Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Heparin Sodium Injection Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Heparin Sodium Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Heparin Sodium Injection Sales by Country (2018-2023) & (K Units)
    Table 42. Latin America Heparin Sodium Injection Sales by Country (2024-2029) & (K Units)
    Table 43. Latin America Heparin Sodium Injection Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Heparin Sodium Injection Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Heparin Sodium Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Heparin Sodium Injection Sales by Country (2018-2023) & (K Units)
    Table 47. Middle East & Africa Heparin Sodium Injection Sales by Country (2024-2029) & (K Units)
    Table 48. Middle East & Africa Heparin Sodium Injection Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Heparin Sodium Injection Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Heparin Sodium Injection Sales (K Units) by Type (2018-2023)
    Table 51. Global Heparin Sodium Injection Sales (K Units) by Type (2024-2029)
    Table 52. Global Heparin Sodium Injection Sales Market Share by Type (2018-2023)
    Table 53. Global Heparin Sodium Injection Sales Market Share by Type (2024-2029)
    Table 54. Global Heparin Sodium Injection Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Heparin Sodium Injection Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Heparin Sodium Injection Revenue Market Share by Type (2018-2023)
    Table 57. Global Heparin Sodium Injection Revenue Market Share by Type (2024-2029)
    Table 58. Global Heparin Sodium Injection Price (USD/Unit) by Type (2018-2023)
    Table 59. Global Heparin Sodium Injection Price (USD/Unit) by Type (2024-2029)
    Table 60. Global Heparin Sodium Injection Sales (K Units) by Application (2018-2023)
    Table 61. Global Heparin Sodium Injection Sales (K Units) by Application (2024-2029)
    Table 62. Global Heparin Sodium Injection Sales Market Share by Application (2018-2023)
    Table 63. Global Heparin Sodium Injection Sales Market Share by Application (2024-2029)
    Table 64. Global Heparin Sodium Injection Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Heparin Sodium Injection Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Heparin Sodium Injection Revenue Market Share by Application (2018-2023)
    Table 67. Global Heparin Sodium Injection Revenue Market Share by Application (2024-2029)
    Table 68. Global Heparin Sodium Injection Price (USD/Unit) by Application (2018-2023)
    Table 69. Global Heparin Sodium Injection Price (USD/Unit) by Application (2024-2029)
    Table 70. Shenzhen Hepalink Corporation Information
    Table 71. Shenzhen Hepalink Description and Business Overview
    Table 72. Shenzhen Hepalink Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 73. Shenzhen Hepalink Heparin Sodium Injection Product
    Table 74. Shenzhen Hepalink Recent Developments/Updates
    Table 75. Bioibérica Corporation Information
    Table 76. Bioibérica Description and Business Overview
    Table 77. Bioibérica Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 78. Bioibérica Heparin Sodium Injection Product
    Table 79. Bioibérica Recent Developments/Updates
    Table 80. Nanjing King-friend Corporation Information
    Table 81. Nanjing King-friend Description and Business Overview
    Table 82. Nanjing King-friend Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 83. Nanjing King-friend Heparin Sodium Injection Product
    Table 84. Nanjing King-friend Recent Developments/Updates
    Table 85. Pfizer Corporation Information
    Table 86. Pfizer Description and Business Overview
    Table 87. Pfizer Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 88. Pfizer Heparin Sodium Injection Product
    Table 89. Pfizer Recent Developments/Updates
    Table 90. Dongcheng Biochemicals Corporation Information
    Table 91. Dongcheng Biochemicals Description and Business Overview
    Table 92. Dongcheng Biochemicals Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 93. Dongcheng Biochemicals Heparin Sodium Injection Product
    Table 94. Dongcheng Biochemicals Recent Developments/Updates
    Table 95. Changzhou Qianhong Bio-pharma Corporation Information
    Table 96. Changzhou Qianhong Bio-pharma Description and Business Overview
    Table 97. Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 98. Changzhou Qianhong Bio-pharma Heparin Sodium Injection Product
    Table 99. Changzhou Qianhong Bio-pharma Recent Developments/Updates
    Table 100. Changshan Biochemical Corporation Information
    Table 101. Changshan Biochemical Description and Business Overview
    Table 102. Changshan Biochemical Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 103. Changshan Biochemical Heparin Sodium Injection Product
    Table 104. Changshan Biochemical Recent Developments/Updates
    Table 105. Pharma Action Corporation Information
    Table 106. Pharma Action Description and Business Overview
    Table 107. Pharma Action Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 108. Pharma Action Heparin Sodium Injection Product
    Table 109. Pharma Action Recent Developments/Updates
    Table 110. Baxter Corporation Information
    Table 111. Baxter Description and Business Overview
    Table 112. Baxter Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 113. Baxter Heparin Sodium Injection Product
    Table 114. Baxter Recent Developments/Updates
    Table 115. Dongying Tiandong Pharmaceutical Corporation Information
    Table 116. Dongying Tiandong Pharmaceutical Description and Business Overview
    Table 117. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 118. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product
    Table 119. Dongying Tiandong Pharmaceutical Recent Developments/Updates
    Table 120. Opocrin Corporation Information
    Table 121. Opocrin Description and Business Overview
    Table 122. Opocrin Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 123. Opocrin Heparin Sodium Injection Product
    Table 124. Opocrin Recent Developments/Updates
    Table 125. Aspen Oss Corporation Information
    Table 126. Aspen Oss Description and Business Overview
    Table 127. Aspen Oss Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 128. Aspen Oss Heparin Sodium Injection Product
    Table 129. Aspen Oss Recent Developments/Updates
    Table 130. Xinbai Pharmaceuticals Corporation Information
    Table 131. Xinbai Pharmaceuticals Description and Business Overview
    Table 132. Xinbai Pharmaceuticals Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 133. Xinbai Pharmaceuticals Heparin Sodium Injection Product
    Table 134. Xinbai Pharmaceuticals Recent Developments/Updates
    Table 135. Yino Pharma Limited Corporation Information
    Table 136. Yino Pharma Limited Description and Business Overview
    Table 137. Yino Pharma Limited Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 138. Yino Pharma Limited Heparin Sodium Injection Product
    Table 139. Yino Pharma Limited Recent Developments/Updates
    Table 140. Sichuan Deebio Corporation Information
    Table 141. Sichuan Deebio Description and Business Overview
    Table 142. Sichuan Deebio Heparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 143. Sichuan Deebio Heparin Sodium Injection Product
    Table 144. Sichuan Deebio Recent Developments/Updates
    Table 145. Key Raw Materials Lists
    Table 146. Raw Materials Key Suppliers Lists
    Table 147. Heparin Sodium Injection Distributors List
    Table 148. Heparin Sodium Injection Customers List
    Table 149. Heparin Sodium Injection Market Trends
    Table 150. Heparin Sodium Injection Market Drivers
    Table 151. Heparin Sodium Injection Market Challenges
    Table 152. Heparin Sodium Injection Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Heparin Sodium Injection
    Figure 2. Global Heparin Sodium Injection Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Heparin Sodium Injection Market Share by Type in 2022 & 2029
    Figure 4. 1, 000 USP Units / mL Product Picture
    Figure 5. 5, 000 USP Units / mL Product Picture
    Figure 6. 10, 000 USP Units / mL Product Picture
    Figure 7. Global Heparin Sodium Injection Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Heparin Sodium Injection Market Share by Application in 2022 & 2029
    Figure 9. Treatment of Venous Thromboembolism
    Figure 10. Complications of Pregnancy
    Figure 11. Cardioversion of Atrial Fibrillation/Flutter
    Figure 12. Other
    Figure 13. Global Heparin Sodium Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Heparin Sodium Injection Market Size (2018-2029) & (US$ Million)
    Figure 15. Global Heparin Sodium Injection Sales (2018-2029) & (K Units)
    Figure 16. Global Heparin Sodium Injection Average Price (USD/Unit) & (2018-2029)
    Figure 17. Heparin Sodium Injection Report Years Considered
    Figure 18. Heparin Sodium Injection Sales Share by Manufacturers in 2022
    Figure 19. Global Heparin Sodium Injection Revenue Share by Manufacturers in 2022
    Figure 20. The Global 5 and 10 Largest Heparin Sodium Injection Players: Market Share by Revenue in 2022
    Figure 21. Heparin Sodium Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 22. Global Heparin Sodium Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 23. North America Heparin Sodium Injection Sales Market Share by Country (2018-2029)
    Figure 24. North America Heparin Sodium Injection Revenue Market Share by Country (2018-2029)
    Figure 25. U.S. Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 26. Canada Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Europe Heparin Sodium Injection Sales Market Share by Country (2018-2029)
    Figure 28. Europe Heparin Sodium Injection Revenue Market Share by Country (2018-2029)
    Figure 29. Germany Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 30. France Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. U.K. Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Italy Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Russia Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Asia Pacific Heparin Sodium Injection Sales Market Share by Region (2018-2029)
    Figure 35. Asia Pacific Heparin Sodium Injection Revenue Market Share by Region (2018-2029)
    Figure 36. China Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 37. Japan Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. South Korea Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. India Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Australia Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Taiwan Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. Indonesia Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Thailand Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Malaysia Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Philippines Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Latin America Heparin Sodium Injection Sales Market Share by Country (2018-2029)
    Figure 47. Latin America Heparin Sodium Injection Revenue Market Share by Country (2018-2029)
    Figure 48. Mexico Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Argentina Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Middle East & Africa Heparin Sodium Injection Sales Market Share by Country (2018-2029)
    Figure 52. Middle East & Africa Heparin Sodium Injection Revenue Market Share by Country (2018-2029)
    Figure 53. Turkey Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. U.A.E Heparin Sodium Injection Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. Global Sales Market Share of Heparin Sodium Injection by Type (2018-2029)
    Figure 57. Global Revenue Market Share of Heparin Sodium Injection by Type (2018-2029)
    Figure 58. Global Heparin Sodium Injection Price (USD/Unit) by Type (2018-2029)
    Figure 59. Global Sales Market Share of Heparin Sodium Injection by Application (2018-2029)
    Figure 60. Global Revenue Market Share of Heparin Sodium Injection by Application (2018-2029)
    Figure 61. Global Heparin Sodium Injection Price (USD/Unit) by Application (2018-2029)
    Figure 62. Heparin Sodium Injection Value Chain
    Figure 63. Heparin Sodium Injection Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS